Company Description: Synvivia optimizes cells for gene therapy manufacturing. Our technology increases gene therapy yield and potency by 3-10X, with thousands of improvements in the pipeline. Our products synergize when combined, opening a path toward 100X improvements. Our key innovation is a high throughput chemical-virology platform​. Our experimental platform is matched by a predictive and generative AI design component made possible by over 50 million proprietary data points. Our technology represents a new way of manipulating and measuring biology. We are setting up pilots with the world’s largest biopharmaceutical manufacturers.